SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-001769
Filing Date
2019-08-14
Accepted
2019-08-14 08:48:32
Documents
8
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 10351
2 NEWS RELEASE DATED AUGUST 14, 2019 ex991.htm EX-99.1 45632
3 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED JU ex992.htm EX-99.2 338530
4 FORM 51-102F1 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE NINE MONTHS ENDED JUNE ex993.htm EX-99.3 283772
5 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS - CEO ex994.htm EX-99.4 7335
6 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS - CFO ex995.htm EX-99.5 7285
7 GRAPHIC logo.jpg GRAPHIC 50798
8 GRAPHIC logo_footer.jpg GRAPHIC 2957
  Complete submission text file 0001279569-19-001769.txt   768229
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 191023058
SIC: 2834 Pharmaceutical Preparations